Portal de Periódicos da CAPES

Interferon and Delta Hepatitis

1988; American College of Physicians; Volume: 109; Issue: 9 Linguagem: Inglês

10.7326/0003-4819-109-9-760_1

1539-3704

B Taillan,

Hepatitis Viruses Studies and Epidemiology

Letters and Corrections1 November 1988Interferon and Delta HepatitisBruno Taillan, MD, Jean-Gabriel Fuzibet, MD, Henri Vinti, MD, Alain Pesce, MD, Jill-Patrice Cassuto, MD, Pierre Dujardin, MDBruno Taillan, MDSearch for more papers by this author, Jean-Gabriel Fuzibet, MDSearch for more papers by this author, Henri Vinti, MDSearch for more papers by this author, Alain Pesce, MDSearch for more papers by this author, Jill-Patrice Cassuto, MDSearch for more papers by this author, Pierre Dujardin, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-109-9-760_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editor: Aach (1) states that interferon is the most promising antiviral agent for treating patients with chronic type B viral hepatitis. For patients at risk for infection with human immunodeficiency virus (HIV), however, antiviral agents do not appear to be the optimal treatment of chronic type B viral hepatitis in those patients who may be simultaneously infected with hepatitis delta virus (2). We report eight cases of severe liver disease due to hepatitis B virus and concurrent hepatitis delta virus infections in patients treated with recombinant alpha-2-interferon, 5 MU three times a week for 6 months.All patients...References1. Aach R. The treatment of chronic type B viral hepatitis. Ann Intern Med. 1988;109:89-91. LinkGoogle Scholar2. Garcia G, Smith C, and Weissberg J. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B: a randomized double-blinded, placebo-controlled trial. Ann Intern Med. 1987;107:278-85. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Bruno Taillan, MD; Jean-Gabriel Fuzibet, MD; Henri Vinti, MD; Alain Pesce, MD; Jill-Patrice Cassuto, MD; Pierre Dujardin, MDAffiliations: Cimiez Hospital 06003 Nice France PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byInterferon alpha for chronic hepatitis DTreatment of hepatitis DSection Review: Anti-infectives: Recent developments in the treatment of hepatitis D infectionThe French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trialInterferon in HDV infectionTreatment of chronic type D hepatitis and concomitant human immunodeficiency infection with α-interferonUse of α-interferon in the treatment of chronic delta hepatitis 1 November 1988Volume 109, Issue 9Page: 760-760KeywordsAntiviralsHepatitis AHepatitis B virusHepatitis DHepatitis D virusHIVInfectious diseasesInterferonsLiver diseases ePublished: 1 December 2008 Issue Published: 1 November 1988 PDF downloadLoading ...